LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

Launched by UNIVERSITY OF ALBERTA · Nov 30, 2022

Keywords

ClinConnect Summary

The LONGEVITI Study is researching how to best support people with advanced chronic cancers who are receiving new targeted treatments. These treatments have helped many individuals live longer, sometimes for years, by specifically attacking cancer cells. The study aims to gather information on the experiences of patients taking these therapies, which include treatments for various types of cancer like breast cancer, melanoma, and lung cancer.

To participate in this study, you need to be between 65 and 87 years old and currently taking targeted anti-cancer medications for your condition. If you join the study, you can expect to share your experiences with these treatments, which will help researchers understand how to improve care for others in similar situations. This study is open to all genders and is currently recruiting participants, so if you or someone you know fits the criteria, it could be an opportunity to contribute to important research.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria: taking chronic targeted anti-cancer agents -
• Exclusion Criteria:
• • -